NEW YORK (PRWEB)
October 20, 2021

The Healthcare Technology Report is pleased to announce the Top 25 Women Leaders in Biotechnology of 2021. As we have seen in recent years and months, biotechnology plays a critical role in the well-being of our global society. With the COVID-19 pandemic shining a spotlight on the importance of life sciences, both private and public organizations are providing unprecedented levels of funding and support to companies in the biotech space. The accomplished women selected for this year’s awards have distinguished themselves through their professional achievements and contributions to their organizations. They represent a diverse range of positions, specialties, and backgrounds. This includes women building new companies, women unlocking revolutionary ways to treat deadly diseases, and other top female executives who are helping their companies navigate market expansion, legal considerations, and brand awareness, among other areas.

These exceptional leaders were selected based on hundreds of nominations and comprehensive analysis of professional milestones achieved, longevity in the biotech field and demonstrated domain expertise. Further research was conducted using a broad set of data including feedback from colleagues, industry influence, key company events milestones, previous honors and recognition, and numerous other metrics.

Please join us in recognizing the achievements of the Top 25 Women Leaders in Biotechnology of 2021.

Eun Young Yang (Samsung Biologics), Stephanie Gutendorf (GRAIL), Qiutang Li (Neurophth Therapeutics), Mariola Fotin-Mleczek (CureVac), Alice Chen (GRAIL), Jaimie Augustine (COPAN Diagnostics), Angela Cacace (Arvinas), Erin DeRuggiero (TI Health), Fay Christodoulou (Miroculus), Elaine Chiquette (Gelesis), Melanie Goldey (TMRW Life Sciences), Nancy Johnson (BillionToOne), Marguerite Hutchinson (Plexxikon), Swati Deshpande (Datar Cancer Genetics), Jessica Flechtner (Genocea Biosciences), Lea Hachigian (Be Biopharma), Sofia Elizondo (Brightseed), Meredith James (Flagship Biosciences), Juliette Han (Cambrian Biopharma) Natalie Breakfield (NewLeaf Symbiotics), Cynthia Seidel-Dugan (Werewolf Therapeutics), Christine Maurer (Autobahn Therapeutics), Milena Kanova (Palladio Biosciences), Nicole Wagner (LambdaVision), Padideh Kamali-Zare (Darmiyan), Valerie Morisset (Eliem Therapeutics), Kristin Martin (Poseida Therapeutics), Teresa McCarthy (Avidity Biosciences), Diane Tager (Volastra), Amanda Wagner (Immunitas).

The full article can be read at https://thehealthcaretechnologyreport.com/

About Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.

Share article on social media or email: